HTLV-1 and HIV-2 infection are associated with increased mortality in a rural west african community

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  van Tienen, Carla ^a   van der Loeff, Maarten Schim ^b   Peterson, Ingrid ^a   Cotten, Matthew ^a   Andersson, Sören ^c   Holmgren, Birgitta ^d   Vincent, Tim ^a   de Silva, Thushan ^a,e   Rowland Jones, Sarah ^f   Aaby, Peter ^g   Whittle, Hilton ^a  

^a MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

^d LUND UNIVERSITY   (Sweden)

^e MEDICAL RESEARCH COUNCIL   (United Kingdom)

^f JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^g Studies of the Epidemiology of Epilepsy in Demographic Surveillance Systems   (Guinea-Bissau)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; GUINEA-BISSAU; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS 2 INFECTION; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 1 INFECTION; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MORTALITY; RETROVIRUS INFECTION; AGING; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN T CELL LEUKEMIA VIRUS INFECTION; KAPLAN MEIER METHOD; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RURAL POPULATION; STATISTICS;

ADULT; AGED; AGING; FEMALE; FOLLOW-UP STUDIES; GUINEA-BISSAU; HIV INFECTIONS; HIV-2; HTLV-I INFECTIONS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RURAL POPULATION; YOUNG ADULT;

EID: 83355170682     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0029026     Document Type: Article

References (38)

1. Geskus R, Poulin N, Whittle H, Schim van der Loeff M, (2009) A Comparison of Progression of HIV-1 and HIV-2 Infection in The Gambia, Africa, Abstract 13_292. 13th International Workshop on HIV Observational Datababases, Lissabon, Portugal.
2. Verdonck K, Gonzalez E, Van Dooren S, Vandamme AM, Vanham G, et al. (2007) Human T-lymphotropic virus 1: recent knowledge about an ancient infection. Lancet Infect Dis 7: 266-281.
3. Iwata K, Ito S, Saito H, Ito M, Nagatomo M, et al. (1994) Mortality among inhabitants of an HTLV-I endemic area in Japan. Jpn J Cancer Res 85: 231-237.
4. Melbye M, Poulsen AG, Gallo D, Pedersen JB, Biggar RJ, et al. (1998) HTLV-1 infection in a population-based cohort of older persons in Guinea-Bissau, West Africa: risk factors and impact on survival. Int J Cancer 76: 293-298.
5. Holmgren B, da Silva Z, Vastrup P, Larsen O, Andersson S, et al. (2007) Mortality associated with HIV-1, HIV-2, and HTLV-I single and dual infections in a middle-aged and older population in Guinea-Bissau. Retrovirology 4: 85.
6. Orland JR, Wang B, Wright DJ, Nass CC, Garratty G, et al. (2004) Increased mortality associated with HTLV-II infection in blood donors: a prospective cohort study. Retrovirology 1: 4.
7. de Silva TI, van Tienen C, Rowland-Jones SL, Cotten M, (2010) Dual infection with HIV-1 and HIV-2: double trouble or destructive interference? HIV Therapy 4: 305-323.
8. Alabi AS, Jaffar S, Ariyoshi K, Blanchard T, Schim van der Loeff M, et al. (2003) Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients. Aids 17: 1513-1520.
9. Seng R, Gustafson P, Gomes VF, Vieira CS, Rabna P, et al. (2002) Community study of the relative impact of HIV-1 and HIV-2 on intrathoracic tuberculosis. AIDS 16: 1059-1066.
10. Schim van der Loeff MF, Jaffar S, Aveika AA, Sabally S, Corrah T, et al. (2002) Mortality of HIV-1, HIV-2 and HIV-1/HIV-2 dually infected patients in a clinic-based cohort in The Gambia. AIDS 16: 1775-1783.
11. Cooke FJ, Geretti AM, Zuckerman M, (2005) Human T-cell lymphotropic virus antibody prevalence in HIV-1-infected individuals attending a sexual health clinic in South-East London. J Med Virol 76: 143-145.
12. Gabbai AA, Bordin JO, Vieira-Filho JP, Kuroda A, Oliveira AS, et al. (1993) Selectivity of human T lymphotropic virus type-1 (HTLV-1) and HTLV-2 infection among different populations in Brazil. Am J Trop Med Hyg 49: 664-671.
13. Zehender G, Colasante C, De Maddalena C, Bernini F, Savasi V, et al. (2004) High prevalence of human T-lymphotropic virus type 1 (HTLV-1) in immigrant male-to-female transsexual sex workers with HIV-1 infection. J Med Virol 74: 207-215.
14. Brites C, Sampalo J, Oliveira A, (2009) HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression. AIDS Rev 11: 8-16.
15. van Tienen C, Schim van der Loeff MF, Peterson I, Cotten M, Holmgren B, et al. (2010) HTLV-1 in rural Guinea-Bissau: prevalence, incidence and a continued association with HIV between 1990 and 2007. Retrovirology 7: 50.
16. da Silva ZJ, Nielsen J, Andersen A, Oliveira I, Dias F, et al. (2009) Decline in human T-cell lymphotropic virus-1 prevalence in urban areas of Bissau, Guinea-Bissau: exploring the association with HIV infections. AIDS.
17. Larsen O, Andersson S, da Silva Z, Hedegaard K, Sandstrom A, et al. (2000) Prevalences of HTLV-1 infection and associated risk determinants in an urban population in Guinea-Bissau, West Africa. J Acquir Immune Defic Syndr 25: 157-163.
18. Holmgren B, Andersson S, Harding E, Schim van der Loeff M, Vastrup P, et al. (2002) Increased prevalence of HTLV-1 among HIV-2-infected women but not HIV-2-infected men in rural Guinea-Bissau. J Acquir Immune Defic Syndr 30: 342-350.
19. Ariyoshi K, Berry N, Cham F, Jaffar S, Schim van der Loeff M, et al. (2003) Quantification of Human T-lymphotropic virus type I (HTLV-I) provirus load in a rural West African population: no enhancement of human immunodeficiency virus type 2 pathogenesis, but HTLV-I provirus load relates to mortality. J Infect Dis 188: 1648-1651.
20. Norrgren H, Bamba S, Da Silva ZJ, Koivula T, Andersson S, (2010) Higher mortality in HIV-2/HTLV-1 co-infected patients with pulmonary tuberculosis in Guinea-Bissau, West Africa, compared to HIV-2-positive HTLV-1-negative patients. Int J Infect Dis.
21. van Tienen C, Schim van der Loeff M, Zaman SM, Vincent T, Sarge-Njie R, et al. (2010) Two Distinct Epidemics: The Rise of HIV-1 and Decline of HIV-2 Infection Between 1990 and 2007 in Rural Guinea-Bissau. J Acquir Immune Defic Syndr 53: 640-647.
22. Ariyoshi K, Berry N, Wilkins A, Ricard D, Aaby P, et al. (1996) A community based study of human immunodeficiency virus type 2 provirus load in rural village in West Africa. J Infect Dis 173: 245-248.
23. Schim van der Loeff MF, Aaby P, Aryioshi K, Vincent T, Awasana AA, et al. (2001) HIV-2 does not protect against HIV-1 infection in a rural community in Guinea-Bissau. AIDS 15: 2303-2310.
24. Krook A, Albert J, Andersson S, Biberfeld G, Blomberg J, et al. (1997) Prevalence and risk factors for HTLV-II infection in 913 injecting drug users in Stockholm, 1994. J Acquir Immune Defic Syndr Hum Retrovirol 15: 381-386.
25. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, et al. (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med 4: e296.
26. Todd J, Balira R, Grosskurth H, Mayaud P, Mosha F, et al. (1997) HIV-associated adult mortality in a rural Tanzanian population. AIDS 11: 801-807.
27. Berry N, Jaffar S, Schim van der Loeff M, Ariyoshi K, Harding E, et al. (2002) Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers. AIDS Res Hum Retroviruses 18: 1167-1173.
28. Ricard D, Wilkins A, N'Gum PT, Hayes R, Morgan G, et al. (1994) The effects of HIV-2 infection in a rural area of Guinea-Bissau. AIDS 8: 977-982.
29. Poulsen AG, Aaby P, Larsen O, Jensen H, Naucler A, et al. (1997) 9-year HIV-2-associated mortality in an urban community in Bissau, west Africa. Lancet 349: 911-914.
30. Schim van der Loeff M, Larke N, Kaye S, Berry N, Ariyoshi K, et al. (2010) Undetectable plasma viral load predicts normal survival in HIV-2-infected people in a West African village. Retrovirology 7: 46.
31. Cooper S, Schim van der Loeff M, McConkey S, Cooper M, Sarge-Njie R, et al. (2009) Neurological morbidity among human T-lymphotropic-virus-type-1-infected individuals in a rural West African population. J Neurol Neurosurg Psychiatry 80: 66-68.
32. Marinho J, Galvao-Castro B, Rodrigues LC, Barreto ML, (2005) Increased risk of tuberculosis with human T-lymphotropic virus-1 infection: a case-control study. J Acquir Immune Defic Syndr 40: 625-628.
33. Norrgren HR, Bamba S, Larsen O, Da Silva Z, Aaby P, et al. (2008) Increased prevalence of HTLV-1 in patients with pulmonary tuberculosis coinfected with HIV, but not in HIV-negative patients with tuberculosis. J Acquir Immune Defic Syndr 48: 607-610.
34. Holmgren B, Aaby P, Jensen H, Larsen O, da Silva Z, et al. (1999) Increased prevalence of retrovirus infections among older women in Africa. Scand J Infect Dis 31: 459-466.
35. Brinkhof MW, Boulle A, Weigel R, Messou E, Mathers C, et al. (2009) Mortality of HIV-infected patients starting antiretroviral therapy in sub-Saharan Africa: comparison with HIV-unrelated mortality. PLoS Med 6: e1000066.
36. Holmgren B, da Silva Z, Larsen O, Vastrup P, Andersson S, et al. (2003) Dual infections with HIV-1, HIV-2 and HTLV-I are more common in older women than in men in Guinea-Bissau. Aids 17: 241-253.
37. Aaby P, Ariyoshi K, Buckner M, Jensen H, Berry N, et al. (1996) Age of wife as a major determinant of male-to-female transmission of HIV-2 infection: a community study from rural West Africa. Aids 10: 1585-1590.
38. Oliveira I, Jensen-Fangel S, da Silva D, Ndumba A, Medina C, et al. (2010) Epidemic Stevens-Johnson syndrome in HIV patients in Guinea-Bissau: a side effect of the drug-supply policy? AIDS 24: 783-785.